External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules DR Baldwin, J Gustafson, L Pickup, C Arteta, P Novotny, J Declerck, ... Thorax 75 (4), 306-312, 2020 | 158 | 2020 |
What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? EL O'Dowd, TM McKeever, DR Baldwin, S Anwar, HA Powell, JE Gibson, ... Thorax 70 (2), 161-168, 2015 | 90 | 2015 |
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE) LSGE Howard, S Barden, R Condliffe, V Connolly, CWH Davies, ... Thorax 73 (Suppl 2), ii1-ii29, 2018 | 82 | 2018 |
Evaluation of cardiovascular risk in a lung cancer screening cohort M Ruparel, SL Quaife, JL Dickson, C Horst, S Burke, M Taylor, A Ahmed, ... Thorax 74 (12), 1140-1146, 2019 | 67 | 2019 |
Analysis of the baseline performance of five UK lung cancer screening programmes H Balata, M Ruparel, E O'Dowd, M Ledson, JK Field, SW Duffy, SL Quaife, ... Lung Cancer 161, 136-140, 2021 | 51 | 2021 |
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism LS Howard, S Barden, R Condliffe, V Connolly, C Davies, J Donaldson, ... BMJ Open Respiratory Research 5 (1), e000281, 2018 | 36 | 2018 |
Brain metastases following radical surgical treatment of non-small cell lung cancer: is preoperative brain imaging important? EL O’Dowd, M Kumaran, S Anwar, B Palomo, DR Baldwin Lung Cancer 86 (2), 185-189, 2014 | 30 | 2014 |
Defining the road map to a UK national lung cancer screening programme EL O'dowd, RW Lee, AR Akram, EC Bartlett, SH Bradley, K Brain, ... The Lancet Oncology 24 (5), e207-e218, 2023 | 26 | 2023 |
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer EL O'Dowd, I Tietzova, E Bartlett, A Devaraj, J Biederer, M Brambilla, ... European journal of cardio-thoracic surgery 64 (4), ezad302, 2023 | 24 | 2023 |
The future of lung cancer screening: current challenges and research priorities A Burzic, EL O’Dowd, DR Baldwin Cancer Management and Research, 637-645, 2022 | 24 | 2022 |
Lung cancer screening—low dose CT for lung cancer screening: recent trial results and next steps EL O’Dowd, DR Baldwin The British journal of radiology 91 (1090), 20170460, 2018 | 21 | 2018 |
Place of death in patients with lung cancer: a retrospective cohort study from 2004-2013 EL O’Dowd, TM McKeever, DR Baldwin, RB Hubbard PLoS One 11 (8), e0161399, 2016 | 21 | 2016 |
Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard DR Baldwin, EL O'Dowd, I Tietzova, A Kerpel-Fronius, MA Heuvelmans, ... European Respiratory Journal 61 (6), 2023 | 20 | 2023 |
Selection of eligible participants for screening for lung cancer using primary care data EL O'Dowd, K Ten Haaf, J Kaur, SW Duffy, W Hamilton, RB Hubbard, ... Thorax 77 (9), 882-890, 2022 | 20 | 2022 |
Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries EL O’Dowd, M Lüchtenborg, DR Baldwin, TM McKeever, HA Powell, ... Lung Cancer 95, 88-93, 2016 | 20 | 2016 |
Lung cancer screening: new perspective and challenges in Europe JP Van Meerbeeck, E O’Dowd, B Ward, P Van Schil, A Snoeckx Cancers 14 (9), 2343, 2022 | 16 | 2022 |
Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit K Cusworth, E O'Dowd, R Hubbard, P Beckett, MD Peake, I Woolhouse Thorax 70 (10), 1001-1003, 2015 | 16 | 2015 |
Lung cancer for the non-respiratory physician E O'Dowd, J Mackenzie, H Balata Clinical Medicine 21 (6), e578-e583, 2021 | 14 | 2021 |
Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results EL O'Dowd, K Ten Haaf Thorax 74 (9), 825-827, 2019 | 14 | 2019 |
Early diagnosis pivotal to survival in lung cancer. EL O'Dowd, DR Baldwin Practitioner 258 (1776), 2014 | 14 | 2014 |